Products of other enterprises
Technical characteristics
- Release formSyrup
Description
COMPOSTION
Each Biocine® capsule contains Lincomycin Hydrochloride equivalent to 500mg Lincomycin base. Each ml of the sterile solution contains Lincomycin Hydrochloride equivalent to 300mg/ml Lincomycin base in 2ml ampoules. Each 5ml (teaspoonful) Biocine® Syrup contains Lincomycin Hydrochloride equivalent to 250mg Lincomycin base.
Biocine® has been shown to be very effective in the treatment of the following conditions caused by gram-positive aerobes such as Streptococci, Pneumococci and Staphylococci (including penicillinase-producing staphylococci) or by susceptible anaerobic bacteria
1. | Bone and joint infections including osteomyelitis and septic arthritis |
2. | Skin and soft tissue infections such as celllulitis, abscesses, furuncles, impetigo acne and wound infections. |
3. | Upper respiratory infections including tonsilitis, pharyngitis, otitis media, finufits, scarlet fever and as adjuvant therapy for diphtheria. |
4. | Lower respiratory infections such as acute and chronic bronchitis- and pneumonia. |
5. | Septicaemia and endocarditis |
6. | Bacillary dysentary |
7. | Usage in Neonates. Biocine® is well tolerated in neonates and no adverse effects were reported. |
Contact the seller
Biocine
We recommend to see